Yes, we're seeing the same problem with pharmaceuticals and so on. That's fine. It's not for us to debate it. I just asked the question as to why we wouldn't have considered it. I'm not sure I'm satisfied with the answer, but I have your answer.
Seeing no other questions, I want to thank you very much for coming in and presenting again to us. We appreciate the opportunity to have input on this issue. It's very important for many people in Canada, so thank you very much.
And thank you to the committee for their good questions.
With that, I will call the meeting adjourned.